57894-200 : Reopro 2 mg/ml Intravenous Injection, Solution

Labeler: Janssen Biotech, Inc.
Product Type: Human Prescription Drug
Drug Name:  Reopro
Dosage Form: Intravenous Injection, Solution
Application #: BLA103575
Rev. Date: 

NDC Package Codes:

  • 57894-200-01: 1 VIAL, SINGLE‑USE IN 1 BOX (57894‑200‑01) > 5 ML IN 1 VIAL, SINGLE‑USE

Active Ingredients:

  • Abciximab

Dosage Strength:

  • 2 mg/mL

Related Products:

Based on records with the same trade name.
  • 0002-7140 Reopro 2 mg/ml Intravenous Injection, Solution by Eli Lilly and Company


Scan the QR code below to easily reference this data in the future:

NDC 57894-200 QR Code

< Prev: 57894-199Next: 57894-350 >

Related Discussions:

reopro (abciximab) for cardiac ischemic complications
ReoPro(Abciximab) is a monoclonal antibody that blocks the pathway to platelet aggregation and reduces cardiac ischemic ...

Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 7 January 2017.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA